Bridgetech Asia Limited (“BT Asia”) is the pioneer for web based predictive diagnostics in Asia supporting the global drive towards preventive medicine. The global marketplace for healthcare is expected to be the largest in the 21st century driven by baby boomer’s wealth, medical innovations and converging information and communications technology (“ICT”) making it boldly predictive, personalized, transnational and cost effective.
 

BT Asia targets Asia’s new middle class population borne from massive urban migration – they are tech savvy, more health conscious and want the prosperity and quality of life of a modern society. BT Asia’s mission is to gain financial success through promoting the greatest social good and helping every Asian consumer gain access to the world’s best predictive diagnostic technology.
 

With the escalating healthcare cost worldwide and governments seeking to restrict its growth, preventive medicine will assume a more central role in the healthcare system. BT Asia’s holistic approach to building a portfolio of web based predictive diagnostics captures the new market. The global trend of focusing on preventive medicines, which include predictive test, early detection and prevention therapy, is a cost effective alternative to the current chronic and acute care healthcare system. BT Asia’s solution merges predictive diagnostics and ICT to detect disease in early stage. The result: the health of the community is improved and medical cost reduced through the application of preventive intervention.
 

To execute our strategy, BT Asia has assembled a seasoned international management team with extensive operations and healthcare experience. Our team enjoys valuable and longstanding relationship with leading healthcare organizations and the regulatory and medical communities in Asia.